PT1107789E - Composições e métodos para proteger órgãos, tecidos e células de danos mediados pelo sistema imunitário - Google Patents

Composições e métodos para proteger órgãos, tecidos e células de danos mediados pelo sistema imunitário Download PDF

Info

Publication number
PT1107789E
PT1107789E PT99946625T PT99946625T PT1107789E PT 1107789 E PT1107789 E PT 1107789E PT 99946625 T PT99946625 T PT 99946625T PT 99946625 T PT99946625 T PT 99946625T PT 1107789 E PT1107789 E PT 1107789E
Authority
PT
Portugal
Prior art keywords
cells
methods
compositions
immune system
tissue
Prior art date
Application number
PT99946625T
Other languages
English (en)
Inventor
Ernest G Hope
Robert Negrin
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of PT1107789E publication Critical patent/PT1107789E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT99946625T 1998-08-24 1999-08-24 Composições e métodos para proteger órgãos, tecidos e células de danos mediados pelo sistema imunitário PT1107789E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9764098P 1998-08-24 1998-08-24
US38208899A 1999-08-24 1999-08-24

Publications (1)

Publication Number Publication Date
PT1107789E true PT1107789E (pt) 2008-10-08

Family

ID=26793493

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99946625T PT1107789E (pt) 1998-08-24 1999-08-24 Composições e métodos para proteger órgãos, tecidos e células de danos mediados pelo sistema imunitário

Country Status (10)

Country Link
US (1) US20080241194A1 (pt)
EP (2) EP1964572A3 (pt)
JP (1) JP2004503463A (pt)
AT (1) ATE399024T1 (pt)
CA (1) CA2341558A1 (pt)
DE (1) DE69938969D1 (pt)
DK (1) DK1107789T3 (pt)
ES (1) ES2310048T3 (pt)
PT (1) PT1107789E (pt)
WO (1) WO2000010603A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2391434A1 (en) * 1999-11-24 2001-05-31 Ernest G. Hope Anti-angiogenic cellular agent for cancer therapy
CA2520830A1 (en) * 2003-03-31 2004-10-14 Kirin Beer Kabushiki Kaisha Method for inducing differentiation and/or proliferating regulatory t cells using anti-cd52 antibodies and pharmaceutical composition therefor
US20090169540A1 (en) * 2005-03-03 2009-07-02 Inserm (Institute National De La Sane Et De La Recherche Medicle) Use Of An Antagonist Of Epac For Treating Human Cardiac Hypertrophy
ES2875747T3 (es) 2016-01-11 2021-11-11 Univ Leland Stanford Junior Proteínas quiméricas y métodos de inmunoterapia
EA201891619A1 (ru) 2016-01-11 2019-02-28 Те Борд Оф Трастиз Оф Те Лилэнд Стэнфорд Джуниор Юниверсити Химерные белки и способы регулирования экспрессии генов
CN111544585A (zh) 2019-02-11 2020-08-18 北京卡替医疗技术有限公司 一种可助推免疫细胞在体内扩增的佐剂
JP2023519647A (ja) 2020-01-19 2023-05-12 キネオ メディカル テクノロジー カンパニー リミテッド 免疫細胞の機能を向上させる強化受容体
WO2024003833A2 (en) 2022-07-01 2024-01-04 Fundação D. Anna De Sommer Champalimaud E Dr. Carlos Montez Champalimaud - Centro De Investigação Da Fundação Champalimaud Chimeric polypeptide systems and methods of gene regulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995021614A1 (en) * 1994-02-09 1995-08-17 Ariad Pharmaceuticals, Inc. New protein trafficking inhibitors
JP2707407B2 (ja) * 1994-02-23 1998-01-28 呉羽化学工業株式会社 骨マトリックス合成促進剤
JPH107569A (ja) * 1996-06-18 1998-01-13 Kureha Chem Ind Co Ltd ベルベリン誘導体含有ｈｓｐ４７合成抑制剤

Also Published As

Publication number Publication date
EP1107789B1 (en) 2008-06-25
EP1964572A2 (en) 2008-09-03
EP1107789A4 (en) 2004-09-01
EP1964572A3 (en) 2009-03-04
ES2310048T3 (es) 2008-12-16
DK1107789T3 (da) 2008-11-03
ATE399024T1 (de) 2008-07-15
US20080241194A1 (en) 2008-10-02
DE69938969D1 (de) 2008-08-07
JP2004503463A (ja) 2004-02-05
WO2000010603A1 (en) 2000-03-02
EP1107789A1 (en) 2001-06-20
CA2341558A1 (en) 2000-03-02

Similar Documents

Publication Publication Date Title
NZ287335A (en) Copolymer-1 composition substantially free of species of copolymer -1 with a mw of from 4 kda to 8 kda, in particular 6.25 kda to 8.4 kda
AU1826700A (en) Radiopaque implantable collagenous biomaterial device
ZA979961B (en) 5-HT1F agonists
IL98712A0 (en) 2,6-di-alkyl-4-silyl-phenols as antiatherosclerotic agents
GR3035585T3 (en) Polymer film compositions for capsules
EP0650370A4 (en) METHODS AND COMPOSITIONS TARGETED ON SPECIFIC TISSUES.
BG105270A (en) Tetrahydropyridoethers
CA2340728A1 (en) Methods of treating hypertension and compositions for use therein
GB2301591A (en) Cytotoxic T-cell epitopes
PT1107789E (pt) Composições e métodos para proteger órgãos, tecidos e células de danos mediados pelo sistema imunitário
ZA200106734B (en) Fungicide compositions for protecting fruits.
GR3032763T3 (en) Branched polysaccharide, microorganism producing it and compositions containing them
AU1816500A (en) Bleaching compositions
ZA988529B (en) Synergistic herbicidal methods and compositions.
EP0649879A3 (en) Siloxane compositions having high tear resistance.
PL340459A1 (en) Agonists of 5ht1f
AU6849198A (en) Neurotrypsin
MXPA03001986A (es) Composiciones antitromboticas.
ZA931062B (en) Compositions for the treatment of glaucoma.
ZA200110213B (en) The use of the protein UK 114 for inhibiting organ transplant rejection.
ZA9711432B (en) Compositions for the preparation of leather.
ZA9710452B (en) Compositions and methods for the preservation of living tissues.
ZA977262B (en) Low molecular weight dendritic compounds as pharmaceutical agents.